Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 10
1977 7
1978 3
1979 3
1980 4
1981 8
1982 8
1983 8
1984 5
1985 11
1986 12
1987 20
1988 20
1989 21
1990 28
1991 38
1992 38
1993 52
1994 38
1995 48
1996 49
1997 71
1998 70
1999 71
2000 76
2001 69
2002 87
2003 85
2004 86
2005 102
2006 95
2007 111
2008 160
2009 171
2010 162
2011 150
2012 155
2013 169
2014 153
2015 167
2016 148
2017 123
2018 116
2019 140
2020 140
2021 122
2022 119
2023 114
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

3,365 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology of Non-Hodgkin's Lymphoma.
Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Thandra KC, et al. Med Sci (Basel). 2021 Jan 30;9(1):5. doi: 10.3390/medsci9010005. Med Sci (Basel). 2021. PMID: 33573146 Free PMC article. Review.
A predictive model for aggressive non-Hodgkin's lymphoma.
International Non-Hodgkin's Lymphoma Prognostic Factors Project. International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993 Sep 30;329(14):987-94. doi: 10.1056/NEJM199309303291402. N Engl J Med. 1993. PMID: 8141877 Free article. Clinical Trial.
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma.
Phillips T, Chan H, Tam CS, Tedeschi A, Johnston P, Oh SY, Opat S, Eom HS, Allewelt H, Stern JC, Tan Z, Novotny W, Huang J, Trotman J. Phillips T, et al. Blood Adv. 2022 Jun 14;6(11):3472-3479. doi: 10.1182/bloodadvances.2021006083. Blood Adv. 2022. PMID: 35390135 Free PMC article. Clinical Trial.
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
Advani R, Flinn I, Popplewell L, Forero A, Bartlett NL, Ghosh N, Kline J, Roschewski M, LaCasce A, Collins GP, Tran T, Lynn J, Chen JY, Volkmer JP, Agoram B, Huang J, Majeti R, Weissman IL, Takimoto CH, Chao MP, Smith SM. Advani R, et al. N Engl J Med. 2018 Nov 1;379(18):1711-1721. doi: 10.1056/NEJMoa1807315. N Engl J Med. 2018. PMID: 30380386 Free PMC article. Clinical Trial.
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA. Morin RD, et al. Nature. 2011 Jul 27;476(7360):298-303. doi: 10.1038/nature10351. Nature. 2011. PMID: 21796119 Free PMC article.
Non-Hodgkin Lymphoma Metabolism.
Kirsch BJ, Chang SJ, Betenbaugh MJ, Le A. Kirsch BJ, et al. Adv Exp Med Biol. 2021;1311:103-116. doi: 10.1007/978-3-030-65768-0_7. Adv Exp Med Biol. 2021. PMID: 34014537 Free PMC article.
Mitochondrial DNA Fragmentation and Risk of Non-Hodgkin Lymphoma.
Hosgood HD 3rd, Davitt M, Cawthon R, Weinstein SJ, Blechter B, Wong JYY, Rahman ML, Hu W, Männistö S, Albanes D, Rothman N, Lan Q. Hosgood HD 3rd, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2326885. doi: 10.1001/jamanetworkopen.2023.26885. JAMA Netw Open. 2023. PMID: 37531109 Free PMC article.
3,365 results